References
- EckhardtBLFrancisPAParkerBSAndersonRLStrategies for the discovery and development of therapies for metastatic breast cancerNat Rev Drug Discov201211647949722653217
- KustermannSBoessFBunessAA label-free, impedance-based real time assay to identify drug-induced toxicities and differentiate cytostatic from cytotoxic effectsToxicol In Vitro20132751589159522954529
- LimameRWoutersAPauwelsBComparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assaysPLoS One2012710e4653623094027
- ObrARöselováPGrebeňováDKuželováKReal-time monitoring of hematopoietic cell interaction with fibronectin fragment: the effect of histone deacetylase inhibitorsCell Adh Migr7327528223567296
- HamawyMMOliverCMergenhagenSESiraganianRPAdherence of rat basophilic leukemia (RBL-2H3) cells to fibronectin-coated surfaces enhances secretionJ Immunol199214926156211378072
- MatsunagaTTakemotoNSatoTInteraction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemiaNat Med2003991158116512897778
- MobleyJLEnnisEShimizuYDifferential activation-dependent regulation of integrin function in cultured human T-leukemic cell linesBlood1994834103910507906564
- DakerMAhmadMKhooASQuercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cellsCancer Cell Int20121213422809533
- HanusováVKrálováVSchröterováLTrilecováLPakostováASkálováLThe effectiveness of oracin in enhancing the cytotoxicity of doxorubicin through the inhibition of doxorubicin deactivation in breast cancer MCF7 cellsXenobiotica2010401068169020698750
- KumarBYadavALangJTeknosTNKumarPDysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesisPLoS One201275e3760122629428
- Yamashita-KashimaYIijimaSYorozuKPertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft modelsClin Cancer Res201117155060507021700765
- AoudjitFVuoriKIntegrin signaling in cancer cell survival and chemoresistanceChemother Res Pract2012201228318122567280
- IvanoffJTalmeTSundqvistKGThe role of chemokines and extracellular matrix components in the migration of T lymphocytes into three-dimensional substrataImmunology20051141536215606795
- RicardIPayetMDDupuisGClustering the adhesion molecules VLA-4 (CD49d/CD29) in Jurkat T cells or VCAM-1 (CD106) in endothelial (ECV 304) cells activates the phosphoinositide pathway and triggers Ca2+ mobilizationEur J Immunol1997276153015389209507
- HarimaANakasekoCYokotaAFibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5Hematology200813423624318796250
- PankovRYamadaKMFibronectin at a glanceJ Cell Sci2002115Pt 203861386312244123
- MudryREFortneyJEYorkTHallBMGibsonLFStromal cells regulate survival of B-lineage leukemic cells during chemotherapyBlood20009651926193210961896
- BradstockKFGottliebDJInteraction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual diseaseLeuk Lymphoma1995181–21168580810
- MeadsMBGatenbyRADaltonWSEnvironment-mediated drug resistance: a major contributor to minimal residual diseaseNat Rev Cancer20099966567419693095
- MeadsMBHazlehurstLADaltonWSThe bone marrow microenvironment as a tumor sanctuary and contributor to drug resistanceClin Cancer Res20081492519252618451212